SAI Global GRC Community

GRC COMMUNITY
Building Organizational Integrity.
News >> Consumer Protection >> CVS to Pay US$5 Million in Reimbursement Over Deceptive Pricing

13
Jan
2012

CVS to Pay US$5 Million in Reimbursement Over Deceptive Pricing


The US Federal Trade Commission (FTC) has announced that CVS Caremark Corporation (CVS) has agreed to settle claims of deceptive pricing relating to some prescription drugs and will pay US$5 million in reimbursements to seniors and disabled customers to whom it allegedly "misrepresented the prices of certain Medicare Part D prescription drugs". According to the FTC, the deceptive pricing resulted in consumers paying "significantly more for their drugs than they expected" and led them to fall within "the coverage gap where none of their drug costs are reimbursed".

FTC's media release (12 January 2012)
(Source: FTC)

World Watch

SAI Global World Watch delivers top news stories, case summaries and notifications surrounding regulatory alerts and best practices in global compliance, ethics and culture. Hand crafted by editors worldwide and containing links to all primary sources of information, World Watch is updated weekly.

Login to post comments

© 2013 SAI Global Limited ABN 67 050 611 642

Login

LOG IN

Register

User Registration
or Cancel